ImmuPharma plc
ImmuPharma plc (IMMPF) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · IMMPF · as of Jun 8, 2026
Key Statistics
Explore ImmuPharma plc Data
immpf stock data · financialsCompetitors & Peers
immpf competitorsIMMPF
ACOGF
CHBRF
DMTTF
EMMLF
GENHStock Performance
Full HistoryAbout ImmuPharma plc
ImmuPharma plc established in London, United Kingdom, in 1999, is a biopharmaceutical company dedicated to discovering and advancing peptide-based therapeutics. These treatments are focused on tackli…
what is immupharma plc · immpf stock overview · immupharma plc company profile · who is immupharma plc ceo · immpf OTC · immupharma plc headquarters · immupharma plc business segments
About Stock Overview & Key Data
ImmuPharma plc (IMMPF) is a Healthcare company in the Biotechnology industry, listed on OTC since Feb 8, 2017. As of the latest trading session, IMMPF stock price is $0.09, with a market capitalization of $28.3M. The stock has returned +0.00% over the past 12 months and +0.00% year-to-date.
Frequently Asked Questions
As of the latest trading session, ImmuPharma plc (IMMPF) stock price is $0.09. The stock is traded on OTC under the ticker symbol IMMPF. The 52-week range is $0.08 – $0.09.